BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Ocugen, Inc. Announces Removal of Clinical Hold on Investigational New Drug Application for OCU200 Phase 1 Clinical Trial

  October 9, 2024

   · 

  4 min read
• Press Releases

  Novavax’s Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Receives Authorization in the EU

  October 9, 2024

   · 

  8 min read
• Press Releases

  Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment

  October 9, 2024

   · 

  4 min read
• Press Releases

  Zai Lab to Present Data from Phase 1 Trial of ZL-1310, Its Investigational Antibody-Drug Conjugate (ADC) for DLL3+ Solid Tumors, at EORTC-NCI-AACR Symposium (ENA) 2024

  October 9, 2024

   · 

  4 min read
• Press Releases

  Auron to Present AUTX-703 Preclinical Data 2024 ENA Symposium

  October 9, 2024

   · 

  1 min read
• Press Releases

  Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit

  October 9, 2024

   · 

  1 min read
• Press Releases

  ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine

  October 9, 2024

   · 

  5 min read
• Press Releases

  Clene to Present at Upcoming October Conferences

  October 9, 2024

   · 

  1 min read
• Press Releases

  DiaMedica Therapeutics Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia

  October 9, 2024

   · 

  8 min read
• Press Releases

  BIOTECanada Welcomes Three New Members to its Board of Directors

  October 9, 2024

   · 

  1 min read